EL
59
-2
PG
43
2
DTE
42
4
CPB
37
2
D
45
4
FIS
73
11
OMC
55
-7
LNC
70
-2
ES
50
3
HPE
68
-5
FITB
72
2
KO
44
2
IBM
67
2
EXR
26
2
EQT
51
-5
ETN
61
2
EXPD
48
-2
PSA
37
2
LH
48
2
AEE
58
3
EL
59
-2
PG
43
2
DTE
42
4
CPB
37
2
D
45
4
FIS
73
11
OMC
55
-7
LNC
70
-2
ES
50
3
HPE
68
-5
FITB
72
2
KO
44
2
IBM
67
2
EXR
26
2
EQT
51
-5
ETN
61
2
EXPD
48
-2
PSA
37
2
LH
48
2
AEE
58
3
Financhill
Back

CytoMed Therapeutics Ltd. Vs. Viking Therapeutics, Inc. Industry Stock Comparison

Sell
27

GDTC
CytoMed Therapeutics Ltd.

Last Price:
$1.53
Seasonality Move:
-6.92%
Sell
50

VKTX
Viking Therapeutics, Inc.

Last Price:
$37.35
Seasonality Move:
16.02%
Sell
27
CytoMed Therapeutics Ltd. (GDTC) is a Sell

Is CytoMed Therapeutics Ltd. a Buy, Sell or Hold?

  • The current CytoMed Therapeutics Ltd. [GDTC] share price is $1.54. The Score for GDTC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • GDTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Viking Therapeutics, Inc. (VKTX) is a Sell

Is Viking Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Viking Therapeutics, Inc. [VKTX] share price is $37.35. The Score for VKTX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GDTC Stock Price Chart

What is CytoMed Therapeutics Ltd.'s stock price today?

  • The CytoMed Therapeutics Ltd. share price today is $1.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing slight selling pressure.

VKTX Stock Price Chart

What is Viking Therapeutics, Inc.'s stock price today?

  • The Viking Therapeutics, Inc. share price today is $37.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing slight buying pressure.

GDTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: -430 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.57 - 1.87) Sell
Bollinger Bands (100): (1.71 - 2.19) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.47 Buy
Relative Strength Index (14 RSI): 55.68 Buy
Chaikin Money Flow: 675823 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.6 - 37.42) Buy
Bollinger Bands (100): (27.56 - 37.98) Buy

GDTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.56 Sell
20-day SMA: 1.68 Sell
50-day SMA: 1.96 Sell
200-day SMA: 2.11 Sell
8-day EMA: 1.56 Sell
20-day EMA: 1.67 Sell
50-day EMA: 1.84 Sell
200-day EMA: 2.07 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.56 Buy
20-day SMA: 36.28 Buy
50-day SMA: 36.14 Buy
200-day SMA: 30.31 Buy
8-day EMA: 27.96 Buy
20-day EMA: 16.08 Buy
50-day EMA: 7.58 Buy
200-day EMA: 2.06 Buy

CytoMed Therapeutics Ltd. Earnings Growth & GDTC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.

CytoMed Therapeutics Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):